ArticleMolecular biology reports2026
Mimosa pudica L. extract attenuates endometrial hyperplasia and proliferation of its malignant cell lines: transcript-level insights from a dual in vivo-in vitro model.
Article in Molecular biology reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
backgroundEndometrium is the innermost layer of the uterus that respond to and synthesize estrogens in connection with its synchronized thickening and shedding during menstrual cycle. Since its thickening is essential for implantation of the embryo, its hyperplasia at chronicity could lead to uterus-associated infertility. if untreated.
methodsQualitative and quantitative analysis of phytochemical constituents, antioxidant efficacy, and GC-MS analysis of M. pudica leaf extract were done. The antiproliferative efficacy of the extract was assessed by MTT assay, fluorescent staining, and mRNA studies of apoptotic-related genes in endometrial cancer cells (Ishikawa and AN3CA). About 25 female rats were assigned to five groups, control (Group 1) and DES-induced endometrial hyperplasia (Groups 2-5). in this, Groups 3-5 were treated with M. pudica leaf extract at increasing doses to assess its restorative efficacy in terms of estrous cycle, structure of ovary, and uterine weight adopting quantification of hormones, ROS, and mRNA expression of genes associated with inflammation (IL-6, NCOR1, and DLK1), angiogenesis (VEGF), and progression of endometrial hyperplasia (ARID1A, SMARCA4, PIK3CA and KRAS).
resultsAdministration of M. pudica leaf extract restored the estrous cycle, bringing to normalcy the structure and function of the ovary and uterus, balancing hormones, and reducing inflammation. The expression of ARID1A and SMARCA4, were enhanced while those of genes associated with proliferation, angiogenesis, and inflammation were mitigated.
conclusionM. pudica leaf extract is potentially effective as a therapeutic agent against endometrial hyperplasia and its cancer cell proliferation by restoring nearly all the dysregulations up to mRNA expression level.
Indexed as
Identifiers
42909521What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.